Due to advances in early detection and cancer therapy, cancer survivors are a rapidly growing population.
Worldwide, there are over 33 million cancer survivors, including over 300,000 living in Switzerland. Many
cancer survivors have substantial physical and psychosocial morbidity following their therapy and are at risk
for premature death. Thus, many have advocated for risk-based health care of cancer survivors which includes
surveillance for recurrence of the cancer, surveillance for second cancers, screening and management of longterm
and late effects, and prevention.
